The Revised Geneva result estimates PE probability before imaging. Low scores generally support D-dimer-first strategies, while high scores typically warrant direct imaging.

It is a pathway tool and should be interpreted with symptoms, hemodynamics, and clinical context.

Use Revised Geneva in adults with suspected pulmonary embolism when you need an objective pretest probability framework to guide D-dimer versus direct imaging decisions.

It is particularly useful where standardized, reproducible scoring is preferred across teams.

Revised Geneva does not include clinician gestalt and may underperform in atypical presentations. It should not delay urgent imaging in unstable patients.

As with other pretest scores, accuracy depends on correct data capture and appropriate pathway selection.